New blood test can detect genes that drive cancer and help to determine best treatmentBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2825 (Published 01 May 2013) Cite this as: BMJ 2013;346:f2825
- Zosia Kmietowicz
Researchers have developed a new blood test that they say could be used to identify women whose breast cancer was being driven by the HER2 gene and who could benefit from treatment with trastuzumab (Herceptin) and similar drugs. They believe that the test could be adapted to a range of other cancers and drug targets.
At the moment women whose breast cancer relapses after initial treatment need to have a biopsy to determine which treatments the cancer is most likely to respond to. But cancers can acquire and lose genes over time, and …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial